Stock To Watch: Abbott Laboratories (NYSE:ABT)


The leading market experts have placed a mean price target of $47.79 on Abbott Laboratories (NYSE:ABT) stock. This price level, which is estimated to be attained in one-year indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.66 a share for the upcoming quarter and $2.20 for the current fiscal. Technical View The technical analysis of Abbott Laboratories Common Stoc plainly substantiates that the 50-day moving average of Abbott Laboratories Common Stoc is $40.49, and stock is hovering 4.26 or +10.53% distant from $40.49. It is noted that the 200-day MA is $40.00, and Abbott Laboratories Common Stoc stock is $4.75 or +11.88% off from this point. Abbott Laboratories (NYSE:ABT) 52-week high is $51.17 and the 52-week low is $36.00. This explains if the stock moves $-6.42, it will post a 52-week high. In event of $+24.31% points decline, a 52-week low will be hit. Taking the Valuation Aspect To emphasize the valuation of Abbott Laboratories Common Stoc, shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Abbott Laboratories (NYSE:ABT) ratio came in at 29.54. The stock last ended the trading session at $44.75 and registered a market cap of $65.74B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Abbott Laboratories (NYSE:ABT) PEG ratio is at 2.17.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 16 times, 1 visits today)